Isoliquiritigen Enhances the Antitumour Activity and Decreases the Genotoxic Effect of Cyclophosphamide

The aim of this study was to evaluate the antitumour activities and genotoxic effects of isoliquiritigenin (ISL) combined with cyclophosphamide (CP) in vitro and in vivo. U14 cells were treated with either of ISL (5–25 μg/mL) or CP (0.25–1.25 mg/mL) alone or with combination of ISL (5–25 μg/mL) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hong, Yuan, Xuan, Li, Defang, Chen, Hongmei, Jiang, Jiangtao, Wang, Zhiping, Sun, Xiling, Zheng, Qiusheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270523/
https://www.ncbi.nlm.nih.gov/pubmed/23887720
http://dx.doi.org/10.3390/molecules18088786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270523/
https://www.ncbi.nlm.nih.gov/pubmed/23887720
http://dx.doi.org/10.3390/molecules18088786

Ejemplares similares